Two years af­ter U2 dis­ap­point­ment, TG Ther­a­peu­tics wins back in­vestors with PFS win — set­ting the stage for NDA

Sep­tem­ber 2018 was sup­posed to hold a cru­cial mo­ment for TG Ther­a­peu­tics. It was the month that re­searchers were due to an­a­lyze the over­all re­sponse …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.